Literature DB >> 22009357

Mouse models of the fragile x premutation and the fragile X associated tremor/ataxia syndrome.

Michael R Hunsaker1, Gloria Arque, Robert F Berman, Rob Willemsen, Renate K Hukema.   

Abstract

The use of mutant mouse models of neurodevelopmental and neurodegenerative disease is essential in order to understand the pathogenesis of many genetic diseases such as fragile X syndrome and fragile X-associated tremor/ataxia syndrome (FXTAS). The choice of which animal model is most suitable to mimic a particular disease depends on a range of factors, including anatomical, physiological, and pathological similarities; presence of orthologs of genes of interest; and conservation of basic cell biological and metabolic processes. In this chapter, we will discuss two mouse models of the fragile X premutation which have been generated to study the pathogenesis of FXTAS and the effects of potential therapeutic interventions. Behavioral, molecular, neuropathological, and endocrine features of the mouse models and their relation to human FXTAS are discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22009357      PMCID: PMC4313770          DOI: 10.1007/978-3-642-21649-7_14

Source DB:  PubMed          Journal:  Results Probl Cell Differ        ISSN: 0080-1844


  69 in total

1.  The fragile X prevalence paradox.

Authors:  Paul J Hagerman
Journal:  J Med Genet       Date:  2008-04-15       Impact factor: 6.318

2.  Testicular and pituitary inclusion formation in fragile X associated tremor/ataxia syndrome.

Authors:  Claudia M Greco; Kultida Soontrapornchai; Juthamas Wirojanan; John E Gould; Paul J Hagerman; Randi J Hagerman
Journal:  J Urol       Date:  2007-04       Impact factor: 7.450

3.  Instability of CGG repeats in transgenic mice.

Authors:  Sujatha Baskaran; Sonal Datta; Arundhati Mandal; Neerja Gulati; Satish Totey; Rajesh R Anand; Vani Brahmachari
Journal:  Genomics       Date:  2002-08       Impact factor: 5.736

4.  Clinical and neuropathologic findings in a woman with the FMR1 premutation and multiple sclerosis.

Authors:  Claudia M Greco; Flora Tassone; Dolores Garcia-Arocena; Nicole Tartaglia; Sarah M Coffey; Timothy K Vartanian; James A Brunberg; Paul J Hagerman; Randi J Hagerman
Journal:  Arch Neurol       Date:  2008-08

Review 5.  The fragile-X premutation: a maturing perspective.

Authors:  Paul J Hagerman; Randi J Hagerman
Journal:  Am J Hum Genet       Date:  2004-03-29       Impact factor: 11.025

6.  Altered hypothalamus-pituitary-adrenal gland axis regulation in the expanded CGG-repeat mouse model for fragile X-associated tremor/ataxia syndrome.

Authors:  J R Brouwer; E Severijnen; F H de Jong; D Hessl; R J Hagerman; B A Oostra; R Willemsen
Journal:  Psychoneuroendocrinology       Date:  2008-05-12       Impact factor: 4.905

Review 7.  The FMR1 gene and fragile X-associated tremor/ataxia syndrome.

Authors:  J R Brouwer; R Willemsen; B A Oostra
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-09-05       Impact factor: 3.568

8.  Long uninterrupted CGG repeats within the first exon of the human FMR1 gene are not intrinsically unstable in transgenic mice.

Authors:  C Lavedan; E Grabczyk; K Usdin; R L Nussbaum
Journal:  Genomics       Date:  1998-06-01       Impact factor: 5.736

9.  Lifespan changes in working memory in fragile X premutation males.

Authors:  Kim M Cornish; Cary S Kogan; Lexin Li; Jeremy Turk; Sebastien Jacquemont; Randi J Hagerman
Journal:  Brain Cogn       Date:  2008-12-27       Impact factor: 2.310

10.  Regional FMRP deficits and large repeat expansions into the full mutation range in a new Fragile X premutation mouse model.

Authors:  Ali Entezam; Rea Biacsi; Bonnie Orrison; Tapas Saha; Gloria E Hoffman; Ed Grabczyk; Robert L Nussbaum; Karen Usdin
Journal:  Gene       Date:  2007-03-16       Impact factor: 3.688

View more
  11 in total

Review 1.  Fragile X-associated tremor/ataxia syndrome (FXTAS): pathology and mechanisms.

Authors:  Paul Hagerman
Journal:  Acta Neuropathol       Date:  2013-06-21       Impact factor: 17.088

Review 2.  Using mouse models of autism spectrum disorders to study the neurotoxicology of gene-environment interactions.

Authors:  Jared J Schwartzer; Claire M Koenig; Robert F Berman
Journal:  Neurotoxicol Teratol       Date:  2012-09-07       Impact factor: 3.763

3.  Induced expression of expanded CGG RNA causes mitochondrial dysfunction in vivo.

Authors:  Renate K Hukema; Ronald A M Buijsen; Chris Raske; Lies Anne Severijnen; Ingeborg Nieuwenhuizen-Bakker; Michelle Minneboo; Alex Maas; Rini de Crom; Johan M Kros; Paul J Hagerman; Robert F Berman; Rob Willemsen
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

4.  Reduced activity-dependent protein levels in a mouse model of the fragile X premutation.

Authors:  Ramona E von Leden; Lindsey C Curley; Gian D Greenberg; Michael R Hunsaker; Rob Willemsen; Robert F Berman
Journal:  Neurobiol Learn Mem       Date:  2014-01-23       Impact factor: 2.877

5.  Abnormal semantic processing in females with fragile X-associated tremor/ataxia syndrome.

Authors:  J-C Yang; C Simon; A Schneider; A L Seritan; L Hamilton; P J Hagerman; R J Hagerman; J M Olichney
Journal:  Genes Brain Behav       Date:  2013-12-26       Impact factor: 3.449

Review 6.  RNA-protein interactions in unstable microsatellite diseases.

Authors:  Apoorva Mohan; Marianne Goodwin; Maurice S Swanson
Journal:  Brain Res       Date:  2014-04-04       Impact factor: 3.252

7.  Cerebral protein synthesis in a knockin mouse model of the fragile X premutation.

Authors:  Mei Qin; Tianjian Huang; Zhonghua Liu; Michael Kader; Thomas Burlin; Zengyan Xia; Zachary Zeidler; Renate K Hukema; Carolyn B Smith
Journal:  ASN Neuro       Date:  2014-09-23       Impact factor: 4.146

Review 8.  Mouse models of the fragile X premutation and fragile X-associated tremor/ataxia syndrome.

Authors:  Robert F Berman; Ronald Am Buijsen; Karen Usdin; Elizabeth Pintado; Frank Kooy; Dalyir Pretto; Isaac N Pessah; David L Nelson; Zachary Zalewski; Nicholas Charlet-Bergeurand; Rob Willemsen; Renate K Hukema
Journal:  J Neurodev Disord       Date:  2014-07-30       Impact factor: 4.025

9.  Current Gaps in Understanding the Molecular Basis of FXTAS.

Authors:  Paul J Hagerman
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-05-18

Review 10.  Neurocognitive endophenotypes in CGG KI and Fmr1 KO mouse models of Fragile X-Associated disorders: an analysis of the state of the field.

Authors:  Michael R Hunsaker
Journal:  F1000Res       Date:  2013-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.